Rachel M. Bailey

发表

In vivo functional brain mapping in a conditional mouse model of human tauopathy (taup301l) reveals reduced neural activity in memory formation structures

M. Febo, Jada Lewis, N. Sahara, 2013, Molecular Neurodegeneration.

The prolyl hydroxylase oxygen-sensing pathway is cytoprotective and allows maintenance of mitochondrial membrane potential during metabolic inhibition.

V. Sridharan, H. Kasiganesan, C. Beeson, 2007, American journal of physiology. Cell physiology.

Extensive rod and cone photoreceptor-cell degeneration in rat models of giant axonal neuropathy: implications for gene therapy of human disease

D. Armao, S. Gray, Rachel M. Bailey, 2021, Ophthalmic genetics.

Progranulin Mediates Caspase-Dependent Cleavage of TAR DNA Binding Protein-43

L. Petrucelli, D. Dickson, E. Buratti, 2007, The Journal of Neuroscience.

Organic anion transporter 3 (Oat3/Slc22a8) knockout mice exhibit altered clearance and distribution of penicillin G.

Rachel M. Bailey, Adam L VanWert, D. H. Sweet, 2007, American journal of physiology. Renal physiology.

CHIP regulates leucine-rich repeat kinase-2 ubiquitination, degradation, and toxicity

L. Petrucelli, C. Ross, T. Dawson, 2009, Proceedings of the National Academy of Sciences.

Gene Transfer Therapy for Neurodevelopmental Disorders

Rachel M. Bailey, Sarah E. Sinnett, Kimberly Goodspeed, 2021, Developmental Neuroscience.

Physiologically relevant factors influence tau phosphorylation by leucine‐rich repeat kinase 2

G. Shaw, B. Giasson, Jada Lewis, 2015, Journal of neuroscience research.

AAV9-mediated FIG4 delivery prolongs life span in Charcot Marie Tooth disease type 4J mouse model.

R. Burgess, C. Lutz, S. Gray, 2021, The Journal of clinical investigation.

The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins.

Cam Patterson, Michael Hutton, Leonard Petrucelli, 2007, The Journal of clinical investigation.

Comparison of high-dose intracisterna magna and lumbar puncture intrathecal delivery of AAV9 in mice to treat neuropathies

S. Gray, Rachel M. Bailey, Alejandra Rozenberg, 2020, Brain Research.

Gene Therapy: Novel Approaches to Targeting Monogenic Epilepsies

S. Prasad, B. Minassian, D. Bilder, 2022, Frontiers in Neurology.

Development of Intrathecal AAV9 Gene Therapy for Giant Axonal Neuropathy

D. Armao, S. Gray, Rachel M. Bailey, 2015, Molecular therapy. Methods & clinical development.

Methods for gene transfer to the central nervous system.

S. Gray, Rachel M. Bailey, B. Kantor, 2014, Advances in genetics.

LRRK2 phosphorylates novel tau epitopes and promotes tauopathy

M. Farrer, D. Dickson, B. Giasson, 2013, Acta Neuropathologica.

Identification of potential protein interactors of Lrrk2.

L. Petrucelli, M. Farrer, S. S. Mok, 2007, Parkinsonism & related disorders.

Advancing the pathologic phenotype of giant axonal neuropathy: early involvement of the ocular lens

D. Armao, S. Gray, J. Hooper, 2019, Orphanet Journal of Rare Diseases.

Effects of the C57BL/6 strain background on tauopathy progression in the rTg4510 mouse model

D. Dickson, Jada Lewis, N. Sahara, 2014, Molecular Neurodegeneration.

Autonomic nervous system involvement in the giant axonal neuropathy (GAN) KO mouse: implications for human disease

D. Armao, S. Gray, Rachel M. Bailey, 2016, Clinical Autonomic Research.

Akt and CHIP coregulate tau degradation through coordinated interactions

L. Petrucelli, J. Cheng, M. Birnbaum, 2008, Proceedings of the National Academy of Sciences.

SLC13A5 Deficiency Disorder: From Genetics to Gene Therapy

Judy S. H. Liu, S. Prasad, Kim Nye, 2022, Genes.

Nitrous Oxide Enhances Focused Ultrasound Mediated Delivery of Viral Gene Therapy

Rajiv Chopra, M. Diamond, B. Shah, 2021, bioRxiv.

Neuronal sensitivity to TDP-43 overexpression is dependent on timing of induction

L. Petrucelli, D. Dickson, Jada Lewis, 2012, Acta Neuropathologica.

Lrrk promotes tau neurotoxicity through dysregulation of actin and mitochondrial dynamics

M. Feany, Jada Lewis, Rachel M. Bailey, 2018, PLoS biology.